Home »Scivita Medical Technology Receives 400 Million RMB in Series B Financing

Real-time venture capital and private equity transactions and news

Scivita Medical Technology Co., Ltd., a Hong Kong-based manufacturer of endoscope products, received nearly RMB 400 million in Series B financing.

Supporters include new investors such as Hudson Bay Capital Management and Prime Capital, as well as existing shareholders such as GL Ventures, Lilly Asia Ventures and Matrix Partners China.

The company intends to use this round of funds for the research and development, capacity expansion and domestic and foreign commercialization of innovative products in endoscopes and related fields.

Scivita Medical's products include 3D visualization systems, 4K UHD camera systems, 4K-3D camera systems, 4K endoscopes, 4K arthroscopy, disposable uterine endoscopes, disposable urinary endoscopes, and disposable bronchial endoscopes Wait. In the future, while continuously launching new products, the company will promote the simultaneous certification of related products in China, the United States, Japan, Europe and other countries and regions, and continue to promote products to the global market.

Since its establishment, Scivita Medical has taken globalization as an important strategy, setting up R&D centers in Suzhou, China and Tokyo, Japan to promote the global simultaneous R&D, patent application, registration and commercialization of products, aiming to build a global platform for endoscopy and related fields Innovative products.

About| Advertise| Contact| Terms and Conditions| Disclaimer| News| The Daily Deal Newsletter Privacy Policy FinSMEs is owned by FinSMEs Ltd-86-90 Paul Street-London, UK-EC2A 4NE-Email: [Email Protection]